| 摘要: |
| 纤维蛋白原是凝血过程、血栓形成过程中的重要物质。高纤维蛋白原是各种血栓性疾病重要危险因素,在临床中被认为是疾病状态的标志物。纤维蛋白原及血小板糖蛋白Ⅱb/Ⅲa受体等是血栓性疾病药物研究的重要作用靶点,因此本文将综述纤维蛋白原影响血栓形成的机制及其相关药物研究进展。 |
| 关键词: 纤维蛋白原 血小板糖蛋白Ⅱb/Ⅲa受体 血栓 药物研究 |
| DOI:10.13506/j.cnki.jpr.2019.03.010 |
| 基金项目:国家自然科学基金(No.6200020055A) |
|
|
|
| Research progress of fibrinogen related drugs |
| HUANG Jin,YIN Xiaojian,HUANG Fang |
| (Department of Traditional Chinese Medicine,College of Traditional Chinese Medicine,China Pharmaceutical University, Nanjing 211198,China) |
| Abstract: |
| Fibrinogen is an important substance in the process of blood coagulation and thrombosis. High fibrinogen is a vital risk factor for various thrombotic diseases and is considered a marker of disease status in the clinic. Fibrinogen and platelet glycoprotein IIb/IIIa receptors are vital targets for drug research in thrombotic diseases. Therefore, this paper will review the mechanism of fibrinogen-induced thrombosis and the progress of related drugs. |
| Key words: Fibrinogen Platelet glycoprotein IIb/IIIa receptor Thrombus Drug research |